Vivien Schäfer

433 citations
12 papers · 241 indexed · h-index 8
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers)Acute Myeloid Leukemia Research (6 papers)Chronic Lymphocytic Leukemia Research (5 papers)

In The Last Decade

Vivien Schäfer

12 papers receiving 240 citations

Peers

Vivien Schäfer
Comparison fields: 5 of 26
  • Hematology 182
  • Genetics 126
  • Molecular Biology 95
  • Public Health, Environmental and Occupational Health 42
  • Rheumatology 31
Replace Berna Beverloo with:
Berna Beverloo Netherlands
Pamela Acha Spain
Steven Richebourg France
Rabia Shahswar Germany
Ying‐Jung Huang Taiwan
Abdulsamad Wafa Syria
B. Hilda Ye United States
Matthew Smith United Kingdom
Jana Linhartová Czechia
Linda Gojenola United States
Vivien Schäfer relative to Berna Beverloo Netherlands Berna Beverloo's profile →
Citations per field
00.5×
Berna Beverloo · 1×
Citations per year

Countries citing papers authored by Vivien Schäfer

Since Specialization
Citations

This map shows the geographic impact of Vivien Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivien Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivien Schäfer more than expected).

Fields of papers citing papers by Vivien Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivien Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivien Schäfer. The network helps show where Vivien Schäfer may publish in the future.

Co-authorship network of co-authors of Vivien Schäfer

This figure shows the co-authorship network connecting the top 25 collaborators of Vivien Schäfer. A scholar is included among the top collaborators of Vivien Schäfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivien Schäfer. Vivien Schäfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 4
2 25
3 17
4 12
5 6
6 23
7 21
8 1
9 28
10 88
11 2
12 14

About Vivien Schäfer

Vivien Schäfer is a scholar working on Genetics, Hematology and Molecular Biology, having authored 12 papers that have together received 241 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (182 citations), Genetics (126 citations) and Rheumatology (31 citations). Vivien Schäfer has collaborated with scholars based in Germany, United Kingdom and Czechia. Frequent co-authors include Thomas Ernst, Andreas Hochhaus, Jenny Rinke, Nils Winkelmann, Claudia Haferlach, Janine M. Ziermann, Mathias Schmidt, Alexander Kohlmann, Ekkehard Eigendorff and Susanne Schnittger. Their work appears in journals such as Blood, Clinical Chemistry and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026